Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
about
Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.Photodynamic therapy in head and neck cancer.Enhancement of meta-tetrahydroxyphenylchlorin-sensitized photodynamic treatment on human tumor xenografts using a water-soluble vitamin E analogue, Trolox.Clinical outcomes of photodynamic therapy for head-and-neck cancer.In vivo mTHPC photobleaching in normal rat skin exhibits unique irradiance-dependent features.Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC.Advances in photodynamic therapy for the treatment of head and neck cancers.Assessment of a sheep animal model to optimise photodynamic therapy in the oesophagus.Photodynamic therapy of age-related macular degeneration: History and principles.Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.Uptake and localisation of mTHPC (Foscan) and its 14C-labelled form in normal and tumour tissues of the hamster squamous cell carcinoma model: a comparative study.Foscan uptake and tissue distribution in relation to photodynamic efficacy.Selectivity of the photosensitiser Tookad for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour model.Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinomaPhotodynamic therapy treatment of early oral and laryngeal cancers.Temoporfin (Foscan®, 5,10,15,20-tetra(m-hydroxyphenyl)chlorin)--a second-generation photosensitizer.Antibody-based imaging strategies for cancer.Photodynamic therapy in the upper aerodigestive tract. Overview and outlook.Targeting of a hydrophilic photosensitizer by use of internalizing monoclonal antibodies: A new possibility for use in photodynamic therapy.Time-dependent biodistribution of tetra(m-hydroxyphenyl)chlorin and benzoporphyrin derivative monoacid ring A in the hamster model: comparative fluorescence microscopy study.Effects of fluence rate on cell survival and photobleaching in meta-tetra-(hydroxyphenyl)chlorin-photosensitized Colo 26 multicell tumor spheroids.Experimental evaluation of possible side effects of intra-operative photodynamic therapy on rabbit blood vessels and nerves.Speciation of new tri- and tetra-glucoconjugated tetrapyrrolic macrocycles (porphyrins and chlorins): an electronic molecular spectroscopy study.Photophysical parameters, photosensitizer retention and tissue optical properties completely account for the higher photodynamic efficacy of meso-tetra-hydroxyphenyl-chlorin vs Photofrin.Evaluation of the photosensitizer Tookad for photodynamic therapy on the Syrian golden hamster cheek pouch model: light dose, drug dose and drug-light interval effects.
P2860
Q30664446-43EE2674-F67C-49A3-A906-D641078B35B5Q30773408-3A9A64C1-5201-4078-9551-5FEC215F2556Q30958989-3910CC6B-394A-4F33-9179-D80C83727952Q30973469-5B4F3713-DD25-44E2-9103-7FB46D8D7F3BQ31048239-F7CCA175-3043-4C99-BAB8-D40FB0251BCBQ33178492-D4BB4D07-4FDA-4BC0-87EB-548E3D759408Q33247403-D66DFC65-3C62-4271-8F31-EBCBA92C57ECQ33507579-D5093E90-EB8E-45D1-80BD-06A4E9DC32D9Q35932469-12615D7A-0E5C-4DF0-BD5C-AAAA7D580E6DQ36292866-04E90FD7-F28A-44AE-9E19-58FA72683862Q36646503-7A5C5FCD-BBC5-4707-9950-0943530F0F6CQ36648672-70D8325F-0269-4DEB-9F2F-45B78BE3288FQ36673605-AD9A56D2-C8F6-4F14-A4B4-484C33F1AB79Q36687568-BA15B471-2C8F-4AF0-BC71-03E2742A7615Q36945981-DEC901D7-75C8-47BE-873A-29F21979B44AQ37919156-A6B031B0-D748-42FB-A32D-B399765ABA85Q38218986-0518C378-AC7A-441D-AC48-414C795302DEQ38787155-C1930AEB-4E15-4F0B-A221-F164B4B44985Q39120026-39F20582-AD00-4FE5-82DD-9211CDEFF22CQ42485485-6211DACF-E02A-415B-B8E2-099FBF444F52Q43561280-A45B831F-67D0-448B-B72C-80FB4E7E31ACQ44627076-775A041D-8854-4A57-B6D3-D04ED128078AQ44684203-60DED38A-E7A6-430C-98F4-5CE3BD9AA5B4Q46419468-BAF9E0E6-B72B-4A67-B1BD-6EC79C5AFBD0Q51795760-BF9C2EE5-977C-4B54-8DD7-6299288A2C5E
P2860
Photodynamic therapy for early squamous cell carcinomas of the esophagus, bronchi, and mouth with m-tetra (hydroxyphenyl) chlorin.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Photodynamic therapy for early ...... tetra (hydroxyphenyl) chlorin.
@en
type
label
Photodynamic therapy for early ...... tetra (hydroxyphenyl) chlorin.
@en
prefLabel
Photodynamic therapy for early ...... tetra (hydroxyphenyl) chlorin.
@en
P2093
P1433
P1476
Photodynamic therapy for early ...... tetra (hydroxyphenyl) chlorin.
@en
P2093
Braichotte D
Fontolliet C
Wagnières G
van den Bergh H
P304
P356
10.1001/ARCHOTOL.1997.01900020042006
P577
1997-02-01T00:00:00Z